- Home
- OBIO vs NPWR Comparison
OBIO vs NPWR Comparison
Compare OBIO & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- NPWR
- Stock Information
- Founded
- OBIO 2017
- NPWR 2010
- Country
- OBIO United States
- NPWR United States
- Employees
- OBIO N/A
- NPWR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- NPWR Industrial Machinery/Components
- Sector
- OBIO Health Care
- NPWR Energy
- Exchange
- OBIO Nasdaq
- NPWR Nasdaq
- Market Cap
- OBIO 146.2M
- NPWR 171.3M
- IPO Year
- OBIO N/A
- NPWR N/A
- Fundamental
- Price
- OBIO $2.74
- NPWR $3.70
- Analyst Decision
- OBIO Strong Buy
- NPWR Buy
- Analyst Count
- OBIO 4
- NPWR 2
- Target Price
- OBIO $14.00
- NPWR $4.00
- AVG Volume (30 Days)
- OBIO 227.6K
- NPWR 1.1M
- Earning Date
- OBIO 11-11-2025
- NPWR 11-10-2025
- Dividend Yield
- OBIO N/A
- NPWR N/A
- EPS Growth
- OBIO N/A
- NPWR N/A
- EPS
- OBIO N/A
- NPWR N/A
- Revenue
- OBIO $2,944,000.00
- NPWR $12,000.00
- Revenue This Year
- OBIO $29.26
- NPWR N/A
- Revenue Next Year
- OBIO $10.65
- NPWR N/A
- P/E Ratio
- OBIO N/A
- NPWR N/A
- Revenue Growth
- OBIO 41.61
- NPWR N/A
- 52 Week Low
- OBIO $2.20
- NPWR $1.48
- 52 Week High
- OBIO $6.50
- NPWR $14.28
- Technical
- Relative Strength Index (RSI)
- OBIO 59.98
- NPWR 74.41
- Support Level
- OBIO $2.20
- NPWR $2.94
- Resistance Level
- OBIO $2.89
- NPWR $3.24
- Average True Range (ATR)
- OBIO 0.14
- NPWR 0.30
- MACD
- OBIO 0.04
- NPWR 0.10
- Stochastic Oscillator
- OBIO 78.26
- NPWR 90.99
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.